{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:10:29Z","timestamp":1793945429718,"version":"4.8.0"},"reference-count":259,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04643-1","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:34:18Z","timestamp":1781087658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nanotechnology integration in oncology for advanced nanoparticle based strategies in targeted cancer diagnosis and treatment"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1009-7577","authenticated-orcid":false,"given":"Yosri A.","family":"Fahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim W.","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Kabba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"8","key":"4643_CR1","first-page":"59","volume":"2","author":"A Singh","year":"2023","unstructured":"Singh A, Roghini S. Cancer: unraveling the complexities of uncontrolled growth and metastasis. PEXACY Int J Pharm Sci. 2023;2(8):59\u201373.","journal-title":"PEXACY Int J Pharm Sci"},{"key":"4643_CR2","doi-asserted-by":"crossref","unstructured":"Fahim YA et al. Occupational exposure to heavy metal dust and its hazardous effects on non-ferrous foundry workers\u2019 health. J Chem Health Risks, 2024. 14(3).","DOI":"10.21203\/rs.3.rs-4295361\/v1"},{"key":"4643_CR3","doi-asserted-by":"crossref","unstructured":"Bizuayehu HM et al. Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population-based estimates. 2024.","DOI":"10.1002\/cncr.35458"},{"issue":"8","key":"4643_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/pharmaceutics17080987","volume":"17","author":"RNA Kazi","year":"2025","unstructured":"Kazi RNA, et al. Nanomedicine: the effective role of nanomaterials in healthcare from diagnosis to therapy. Pharmaceutics. 2025;17(8):987.","journal-title":"Pharmaceutics"},{"issue":"11","key":"4643_CR5","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","volume":"50","author":"R Kaur","year":"2023","unstructured":"Kaur R, Bhardwaj A, Gupta SJMBR. Cancer treatment therapies: traditional to modern approaches to combat cancers. Mol Biol Rep. 2023;50(11):9663\u201376.","journal-title":"Mol Biol Rep"},{"key":"4643_CR6","doi-asserted-by":"crossref","unstructured":"Ezike TC et al. Advances in drug delivery systems, challenges and future directions. Heliyon, 2023. 9(6).","DOI":"10.1016\/j.heliyon.2023.e17488"},{"issue":"1","key":"4643_CR7","doi-asserted-by":"publisher","first-page":"17527","DOI":"10.1038\/s41598-025-98478-y","volume":"15","author":"AA Hassan","year":"2025","unstructured":"Hassan AA, et al. Efficient removal of Remazol Red dye from aqueous solution using magnetic nickel ferrite nanoparticles synthesized via aqueous reflux. Sci Rep. 2025;15(1):17527.","journal-title":"Sci Rep"},{"issue":"1","key":"4643_CR8","doi-asserted-by":"publisher","first-page":"1336043","DOI":"10.1080\/20016689.2017.1336043","volume":"5","author":"Y Eroglu","year":"2017","unstructured":"Eroglu Y, Policy H. A comparative review of Haute Autorit\u00e9 de Sant\u00e9 and National Institute for Health and Care Excellence health technology assessments of Ikervis\u00ae to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes. J Market Access Health Policy. 2017;5(1):1336043.","journal-title":"J Market Access Health Policy"},{"key":"4643_CR9","doi-asserted-by":"crossref","unstructured":"Kalomiraki M, Thermos K, Chaniotakis NA. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications. Int J Nanomed, 2016: pp. 1\u201312.","DOI":"10.2147\/IJN.S93069"},{"key":"4643_CR10","first-page":"279","volume":"95","author":"S Reimondez-Troiti\u00f1o","year":"2015","unstructured":"Reimondez-Troiti\u00f1o S, et al. Nanotherapies for the treatment of ocular diseases. Nanotherapies Treat Ocular Dis. 2015;95:279\u201393.","journal-title":"Nanotherapies Treat ocular Dis"},{"issue":"1","key":"4643_CR11","first-page":"12","volume":"4","author":"J Aghajani","year":"2025","unstructured":"Aghajani J, Deljavan Y, Haghighatdoust MJNL. Drug Delivery Options Riluzole Treat Amyotroph Lateral Scler. 2025;4(1):12\u20136.","journal-title":"Drug Delivery Options Riluzole Treat Amyotroph Lateral Scler"},{"issue":"5","key":"4643_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/0897190017725984","volume":"31","author":"C Bell","year":"2018","unstructured":"Bell C, et al. Development of Glatopa\u00ae(glatiramer acetate): the first FDA-approved generic disease-modifying therapy for relapsing forms of multiple sclerosis. J Pharm Pract. 2018;31(5):481\u20138.","journal-title":"J Pharm Pract"},{"issue":"3","key":"4643_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/ph17030315","volume":"17","author":"M Arafat","year":"2024","unstructured":"Arafat M, et al. Nanomedicines: emerging platforms in smart chemotherapy treatment\u2014a recent review. Pharmaceuticals. 2024;17(3):315.","journal-title":"Pharmaceuticals"},{"key":"4643_CR14","doi-asserted-by":"crossref","unstructured":"Kaye AD et al. Exparel for postoperative pain management: a comprehensive review. Curr Pain Headache Rep 2020;24(11):73.","DOI":"10.1007\/s11916-020-00905-4"},{"key":"4643_CR15","doi-asserted-by":"publisher","first-page":"103553","DOI":"10.1016\/j.jddst.2022.103553","volume":"74","author":"B Wilson","year":"2022","unstructured":"Wilson B, Geetha KM. Lipid nanoparticles in the development of mRNA vaccines for COVID-19. J Drug Deliv Sci Technol. 2022;74:103553.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"4643_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324.","journal-title":"Nat Rev Drug Discovery"},{"key":"4643_CR17","doi-asserted-by":"crossref","unstructured":"Palagati S, et al. Advanced materials synthesis by top-down and bottom-up approaches, in Advanced materials. CRC; 2024. pp. 201\u201321.","DOI":"10.1201\/9781003451198-10"},{"issue":"11","key":"4643_CR18","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1039\/C9TA00074G","volume":"7","author":"TS Rodrigues","year":"2019","unstructured":"Rodrigues TS, da Silva AGM, Camargo PHC. Nanocatalysis by noble metal nanoparticles: controlled synthesis for the optimization and understanding of activities. J Mater Chem A. 2019;7(11):5857\u201374.","journal-title":"J Mater Chem A"},{"issue":"4","key":"4643_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s42452-025-06835-3","volume":"7","author":"T Sigauke","year":"2025","unstructured":"Sigauke T, et al. Advancements in nanotechnology for the enhanced flotation of fine mineral particles: a review. Discover Appl Sci. 2025;7(4):317.","journal-title":"Discover Appl Sci"},{"issue":"14","key":"4643_CR20","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1002\/adma.201405408","volume":"27","author":"D Liu","year":"2015","unstructured":"Liu D, et al. A versatile and robust microfluidic platform toward high throughput synthesis of homogeneous nanoparticles with tunable properties. Adv Mater. 2015;27(14):2298\u2013304.","journal-title":"Adv Mater"},{"issue":"2","key":"4643_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/genes9020103","volume":"9","author":"S Damiati","year":"2018","unstructured":"Damiati S, et al. Microfluidic devices for drug delivery systems and drug screening. Genes (Basel). 2018;9(2):103.","journal-title":"Genes (Basel)"},{"key":"4643_CR22","doi-asserted-by":"publisher","first-page":"119408","DOI":"10.1016\/j.ijpharm.2020.119408","volume":"584","author":"SI Hamdallah","year":"2020","unstructured":"Hamdallah SI, et al. Microfluidics for pharmaceutical nanoparticle fabrication: The truth and the myth. Int J Pharm. 2020;584:119408.","journal-title":"Int J Pharm"},{"issue":"7","key":"4643_CR23","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/ph17070908","volume":"17","author":"M Asif","year":"2024","unstructured":"Asif M, et al. Synthesis and characterization of chemically and green-synthesized silver oxide particles for evaluation of antiviral and anticancer activity. Pharmaceuticals (Basel). 2024;17(7):908.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"4643_CR24","doi-asserted-by":"publisher","first-page":"230796","DOI":"10.1098\/rsos.230796","volume":"10","author":"MA Huq","year":"2023","unstructured":"Huq MA, et al. Bacterial mediated green synthesis of silver nanoparticles and their antibacterial and antifungal activities against drug-resistant pathogens. R Soc Open Sci. 2023;10(10):230796.","journal-title":"Royal Soc Open Sci"},{"issue":"5","key":"4643_CR25","first-page":"1560","volume":"13","author":"STG Al-Sahlany","year":"2025","unstructured":"Al-Sahlany STG, Niamah AK, Verma DK, Prabhakar P, Patel AR, Thakur M, Singh S. Applications of green synthesis of nanoparticles using microorganisms in food and dairy products. Processes, 2025;13(5), 1560.","journal-title":"Appl Green Synthesis Nanopart Using Microorganisms Food Dairy Prod"},{"key":"4643_CR26","doi-asserted-by":"crossref","unstructured":"Epp J. X-ray diffraction (XRD) techniques for materials characterization, in Materials characterization using nondestructive evaluation (NDE) methods. Elsevier; 2016. pp. 81\u2013124.","DOI":"10.1016\/B978-0-08-100040-3.00004-3"},{"issue":"7","key":"4643_CR27","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","volume":"12","author":"I Khan","year":"2019","unstructured":"Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019;12(7):908\u201331.","journal-title":"Arab J Chem"},{"key":"4643_CR28","doi-asserted-by":"crossref","unstructured":"Khan SA, et al. Fourier transform infrared spectroscopy: fundamentals and application in functional groups and nanomaterials characterization, in Handbook of materials characterization. Springer; 2018. pp. 317\u201344.","DOI":"10.1007\/978-3-319-92955-2_9"},{"key":"4643_CR29","doi-asserted-by":"crossref","unstructured":"Chevali V, Kandare E. Rigid biofoam composites as eco-efficient construction materials. Biopolymers and Biotech Admixtures for Eco-Efficient Construction Materials. Elsevier; 2016. pp. 275\u2013304.","DOI":"10.1016\/B978-0-08-100214-8.00013-0"},{"issue":"9","key":"4643_CR30","first-page":"660","volume":"5","author":"T Gruene","year":"2021","unstructured":"Gruene T, et al. Establishing electron diffraction. Chem Crystallogr. 2021;5(9):660\u20138.","journal-title":"Establishing electron diffraction Chem Crystallogr"},{"issue":"30","key":"4643_CR31","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.2217\/nnm-2020-0361","volume":"15","author":"T Lin","year":"2020","unstructured":"Lin T, et al. Applications of surface-enhanced Raman spectroscopy in detection fields. Nanomedicine. 2020;15(30):2971\u201389.","journal-title":"Nanomedicine"},{"key":"4643_CR32","doi-asserted-by":"crossref","unstructured":"Abdi-Jalebi M et al. Optical absorption and photoluminescence spectroscopy, in Characterization Techniques for Perovskite Solar Cell Materials. 2020, Elsevier. pp. 49\u201379.","DOI":"10.1016\/B978-0-12-814727-6.00003-7"},{"key":"4643_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.molliq.2015.11.002","volume":"213","author":"S Patel","year":"2016","unstructured":"Patel S, et al. DNA binding and dispersion activities of titanium dioxide nanoparticles with UV\/vis spectrophotometry, fluorescence spectroscopy and physicochemical analysis at physiological temperature. J Mol Liq. 2016;213:304\u201311.","journal-title":"J Mol Liq"},{"issue":"27","key":"4643_CR34","first-page":"12871","volume":"10","author":"S Mourdikoudis","year":"2018","unstructured":"Mourdikoudis S, Pallares RM, Thanh NTJN. Charact techniques nanoparticles: comparison complementarity upon. Stud nanoparticle Prop. 2018;10(27):12871\u2013934.","journal-title":"Charact techniques nanoparticles: comparison complementarity upon Stud nanoparticle Prop"},{"issue":"3","key":"4643_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nmat4500","volume":"15","author":"Y Lykhach","year":"2016","unstructured":"Lykhach Y, et al. Counting electrons on supported nanoparticles. Nat Mater. 2016;15(3):284\u20138.","journal-title":"Nat Mater"},{"key":"4643_CR36","doi-asserted-by":"crossref","unstructured":"Manaia EB et al. Physicochemical characterization of drug nanocarriers. Int J Nanomed, 2017: 4991\u20135011.","DOI":"10.2147\/IJN.S133832"},{"issue":"27","key":"4643_CR37","doi-asserted-by":"publisher","first-page":"12871","DOI":"10.1039\/C8NR02278J","volume":"10","author":"S Mourdikoudis","year":"2018","unstructured":"Mourdikoudis S, Pallares RM, Thanh NTK. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale. 2018;10(27):12871\u2013934.","journal-title":"Nanoscale"},{"issue":"17","key":"4643_CR38","first-page":"10728","volume":"123","author":"G Li","year":"2023","unstructured":"Li G, Zhang H, Han YJCR. Appl transmission electron microscopy phase. Eng Nanomater. 2023;123(17):10728\u201349.","journal-title":"Appl transmission electron microscopy phase Eng nanomaterials"},{"key":"4643_CR39","doi-asserted-by":"crossref","unstructured":"Groarke R et al. Powder characterization\u2014methods, standards, and state of the art. Fundamentals of laser powder bed fusion of metals, 2021: 491\u2013527.","DOI":"10.1016\/B978-0-12-824090-8.00006-8"},{"key":"4643_CR40","doi-asserted-by":"crossref","unstructured":"Nasrollahzadeh M, et al. Plant-mediated green synthesis of nanostructures: mechanisms, characterization, and applications. In: Interface science and technology. Elsevier; 2019. 199\u2013322.","DOI":"10.1016\/B978-0-12-813586-0.00006-7"},{"key":"4643_CR41","doi-asserted-by":"crossref","unstructured":"Naderi M. Surface area: brunauer\u2013emmett\u2013teller (BET), in Progress in filtration and separation. Elsevier; 2015. 585\u2013608.","DOI":"10.1016\/B978-0-12-384746-1.00014-8"},{"key":"4643_CR42","doi-asserted-by":"crossref","unstructured":"Kumar A, Dixit CK. Methods for characterization of nanoparticles. Advances in nanomedicine for the delivery of therapeutic nucleic acids. Elsevier; 2017. 43\u201358.","DOI":"10.1016\/B978-0-08-100557-6.00003-1"},{"issue":"23","key":"4643_CR43","doi-asserted-by":"publisher","first-page":"9835","DOI":"10.1039\/C5AY02014J","volume":"7","author":"A Sikora","year":"2015","unstructured":"Sikora A, et al. A systematic comparison of different techniques to determine the zeta potential of silica nanoparticles in biological medium. Anal Methods. 2015;7(23):9835\u201343.","journal-title":"Anal Methods"},{"key":"4643_CR44","doi-asserted-by":"crossref","unstructured":"Raval N, et al. Importance of physicochemical characterization of nanoparticles in pharmaceutical product development. Basic fundamentals of drug delivery. Elsevier; 2019. 369\u2013400.","DOI":"10.1016\/B978-0-12-817909-3.00010-8"},{"issue":"5","key":"4643_CR45","first-page":"227","volume":"4","author":"BR Kirupakar","year":"2016","unstructured":"Kirupakar BR, et al. Vibrating sample magnetometer and its application in characterisation of magnetic property of the anti cancer drug magnetic microspheres. Int J Pharm Drug Anal. 2016;4(5):227\u201333.","journal-title":"Int J Pharm Drug Anal"},{"issue":"9","key":"4643_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","volume":"13","author":"M Faria","year":"2018","unstructured":"Faria M, et al. Minimum information reporting in bio\u2013nano experimental literature. Nat Nanotechnol. 2018;13(9):777\u201385.","journal-title":"Nat Nanotechnol"},{"issue":"7","key":"4643_CR47","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41565-019-0498-7","volume":"14","author":"HF Florindo","year":"2019","unstructured":"Florindo HF, Madi A, Satchi-Fainaro R. Challenges in the implementation of MIRIBEL criteria on nanobiomed manuscripts. Nat Nanotechnol. 2019;14(7):627\u20138.","journal-title":"Nat Nanotechnol"},{"key":"4643_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.impact.2017.12.004","volume":"10","author":"D Langevin","year":"2018","unstructured":"Langevin D, et al. Inter-laboratory comparison of nanoparticle size measurements using dynamic light scattering and differential centrifugal sedimentation. NanoImpact. 2018;10:97\u2013107.","journal-title":"NanoImpact"},{"key":"4643_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.addr.2015.12.013","volume":"100","author":"S Thakral","year":"2016","unstructured":"Thakral S, et al. Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometry. Adv Drug Deliv Rev. 2016;100:183\u201393.","journal-title":"Adv Drug Deliv Rev"},{"key":"4643_CR50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.colsurfb.2016.08.059","volume":"148","author":"M Nag","year":"2016","unstructured":"Nag M, Gajbhiye V, Kesharwani P, Jain NK. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Colloids Surf B. 2016;148:363\u201370.","journal-title":"Colloids Surf B"},{"issue":"9","key":"4643_CR51","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/cancers13092179","volume":"13","author":"L Guerrini","year":"2021","unstructured":"Guerrini L, Garcia-Rico E, O\u2019loghlen A, Giannini V, Alvarez-Puebla RA. Surface-enhanced Raman scattering (SERS) spectroscopy for sensing and characterization of exosomes in cancer diagnosis. Cancers. 2021;13(9):2179.","journal-title":"Cancers"},{"issue":"7","key":"4643_CR52","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1021\/acs.molpharmaceut.2c00150","volume":"19","author":"J Wang","year":"2022","unstructured":"Wang J, Zhao H, Song W, Gu M, Liu Y, Liu B, Zhan H. Gold nanoparticle-decorated drug nanocrystals for enhancing anticancer efficacy and reversing drug resistance through chemo-\/photothermal therapy. Mol Pharm. 2022;19(7):2518\u201334.","journal-title":"Mol Pharm"},{"issue":"8","key":"4643_CR53","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/nano12081333","volume":"12","author":"F Ahmad","year":"2022","unstructured":"Ahmad F, Salem-Bekhit MM, Khan F, Alshehri S, Khan A, Ghoneim MM, Elbagory I. Unique properties of surface-functionalized nanoparticles for bio-application: functionalization mechanisms and importance in application. Nanomaterials. 2022;12(8):1333.","journal-title":"Nanomaterials"},{"issue":"14","key":"4643_CR54","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.1021\/acsomega.9b04084","volume":"5","author":"B Ahmed","year":"2020","unstructured":"Ahmed B, Ameen F, Rizvi A, Ali K, Sonbol H, Zaidi A, Musarrat J. Destruction of cell topography, morphology, membrane, inhibition of respiration, biofilm formation, and bioactive molecule production by nanoparticles of Ag, ZnO, CuO, TiO2, and Al2O3 toward beneficial soil bacteria. ACS Omega. 2020;5(14):7861\u201376.","journal-title":"ACS omega"},{"issue":"4","key":"4643_CR55","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/micmic\/ozad066","volume":"29","author":"A Kaphle","year":"2023","unstructured":"Kaphle A, et al. Deep learning-based TEM image analysis for fully automated detection of gold nanoparticles internalized within tumor cell. Microsc Microanal. 2023;29(4):1474\u201387.","journal-title":"Microsc Microanal"},{"key":"4643_CR56","doi-asserted-by":"crossref","unstructured":"Talegaonkar S, et al. Metal nanoparticles as a surrogate carrier in drug delivery and diagnostics. Micro-and nanotechnologies-based product development. CRC; 2021. pp. 139\u201361.","DOI":"10.1201\/9781003043164-9"},{"issue":"7","key":"4643_CR57","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/pharmaceutics13070950","volume":"13","author":"K Trzeciak","year":"2021","unstructured":"Trzeciak K, Chotera-Ouda A, Bak-Sypien II, Potrzebowski MJ. Mesoporous silica particles as drug delivery systems\u2014the state of the art in loading methods and the recent progress in analytical techniques for monitoring these processes. Pharmaceutics. 2021;13(7):950.","journal-title":"Pharmaceutics"},{"key":"4643_CR58","first-page":"117","volume":"28","author":"SANAT Karmakar","year":"2019","unstructured":"Karmakar SANAT. Particle size distribution and zeta potential based on dynamic light scattering: Techniques to characterize stability and surface charge distribution of charged colloids. Recent Trends Mater Phys Chem. 2019;28:117\u201359.","journal-title":"Recent Trends Mater Phys Chem"},{"issue":"3","key":"4643_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12013-025-01730-5","volume":"83","author":"TC Jangam","year":"2025","unstructured":"Jangam TC, et al. Exosomes as therapeutic and diagnostic tools: advances, challenges, and future directions. Cell Biochem Biophys. 2025;83(3):1\u201325.","journal-title":"Cell Biochem Biophys"},{"issue":"11","key":"4643_CR60","first-page":"2586","volume":"13","author":"S Caspani","year":"2020","unstructured":"Caspani S, et al. Magn nanomaterials as contrast agents. MRI. 2020;13(11):2586.","journal-title":"Magn nanomaterials as contrast agents MRI"},{"key":"4643_CR61","first-page":"3","volume-title":"Review on the application of porous minerals in the removal of volatile organic compounds: as adsorbent or catalyst carrier","author":"X Liu","year":"2020","unstructured":"Liu X, Wang B. Review on the application of porous minerals in the removal of volatile organic compounds: as adsorbent or catalyst carrier. Volume 62. Petroleum & Coal, UK; 2020. p. 3."},{"issue":"3","key":"4643_CR62","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/jcp.29126","volume":"235","author":"A Aghebati-Maleki","year":"2020","unstructured":"Aghebati-Maleki A, et al. Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers. J Cell Physiol. 2020;235(3):1962\u201372.","journal-title":"J Cell Physiol"},{"issue":"1","key":"4643_CR63","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ. Exosomes. Annual Rev Biochem. 2019;88(1):487\u2013514.","journal-title":"Exosomes Annual Rev Biochem"},{"issue":"3","key":"4643_CR64","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/molecules28031498","volume":"28","author":"GYW Tseu","year":"2023","unstructured":"Tseu GYW, Kamaruzaman KA. A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast cancer. Molecules. 2023;28(3):1498.","journal-title":"Molecules"},{"key":"4643_CR65","doi-asserted-by":"publisher","first-page":"123421","DOI":"10.1016\/j.ijpharm.2023.123421","volume":"646","author":"A Mellinger","year":"2023","unstructured":"Mellinger A, Lubitz LJ, Gazaille C, Leneweit G, Bastiat G, L\u00e9pinoux-Chambaud C, Eyer J. The use of liposomes functionalized with the NFL-TBS. 40\u201363 peptide as a targeting agent to cross the in vitro blood\u2013brain barrier and target glioblastoma cells. Int J Pharm. 2023;646:123421.","journal-title":"Int J Pharm"},{"issue":"7","key":"4643_CR66","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/polym13071027","volume":"13","author":"V De Leo","year":"2021","unstructured":"De Leo V, et al. Recent advancements in polymer\/liposome assembly for drug delivery: from surface modifications to hybrid vesicles. Polymers. 2021;13(7):1027.","journal-title":"Polymers"},{"issue":"1","key":"4643_CR67","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","volume":"20","author":"M Mohamed","year":"2019","unstructured":"Mohamed M, et al. PEGylated liposomes: immunological responses. Sci Technol Adv Mater. 2019;20(1):710\u201324.","journal-title":"Sci Technol Adv Mater"},{"issue":"2","key":"4643_CR68","first-page":"79","volume":"5","author":"M Mohamed","year":"2022","unstructured":"Mohamed M, et al. Complement activation-related pseudo allergy of PEGylated products: Safety aspects, models, the role of anti-PEG antibodies, and ways to overcome. J Adv Biomedical Pharm Sci. 2022;5(2):79\u201387.","journal-title":"J Adv Biomedical Pharm Sci"},{"issue":"4","key":"4643_CR69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/09506608251323568","volume":"70","author":"W He","year":"2025","unstructured":"He W, et al. The advances in zwitterionic materials and their biomedical applications. Int Mater Rev. 2025;70(4):301\u201349.","journal-title":"Int Mater Rev"},{"issue":"6","key":"4643_CR70","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","volume":"15","author":"C Viegas","year":"2023","unstructured":"Viegas C, et al. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics. 2023;15(6):1593.","journal-title":"Pharmaceutics"},{"key":"4643_CR71","doi-asserted-by":"publisher","first-page":"783831","DOI":"10.3389\/fnut.2021.783831","volume":"8","author":"H Lu","year":"2021","unstructured":"Lu H, et al. A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front Nutr. 2021;8:783831.","journal-title":"Front Nutr"},{"key":"4643_CR72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2020.01.011","volume":"69","author":"ES Ali","year":"2021","unstructured":"Ali ES, et al. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. Sem Cancer Biol. 2021;69:52\u201368.","journal-title":"Sem Cancer Biol"},{"key":"4643_CR73","first-page":"101374","volume":"55","author":"KO Affram","year":"2020","unstructured":"Affram KO, et al. Cytotoxic Eff gemcitabine-loaded solid lipid. Nanopart Pancreat Cancer Cells. 2020;55:101374.","journal-title":"Cytotoxic Eff gemcitabine-loaded solid lipid Nanopart Pancreat cancer cells"},{"key":"4643_CR74","doi-asserted-by":"publisher","first-page":"614290","DOI":"10.3389\/fphar.2020.614290","volume":"11","author":"GS Bhagwat","year":"2020","unstructured":"Bhagwat GS, Athawale RB, Gude RP, Md S, Alhakamy NA, Fahmy UA, Kesharwani P. Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy. Front Pharmacol. 2020;11:614290.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4643_CR75","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/1570180817999201001155508","volume":"18","author":"P Yadav","year":"2021","unstructured":"Yadav P, et al. Expanding opportunities in treatment of leukemia by solid lipid nanoparticles. Lett Drug Des Discovery. 2021;18(3):212\u201321.","journal-title":"Lett Drug Des Discovery"},{"issue":"2","key":"4643_CR76","first-page":"127","volume":"20","author":"NAM Shamsuddin","year":"2023","unstructured":"Shamsuddin NAM. Nanostructured lipid carriers delivery. Nat Bioactive Compd. 2023;20(2):127\u201343.","journal-title":"Nanostructured lipid carriers delivery Nat bioactive Compd"},{"key":"4643_CR77","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","volume":"103","author":"A Khosa","year":"2018","unstructured":"Khosa A, Reddi S, Saha RN. Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother. 2018;103:598\u2013613.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"4643_CR78","first-page":"129936","volume":"1865","author":"M Rizwanullah","year":"2021","unstructured":"Rizwanullah M, et al. Advancement Des nanostructured lipid carriers cancer. Target Theranostic Appl. 2021;1865(9):129936.","journal-title":"Advancement Des nanostructured lipid carriers cancer Target theranostic application"},{"key":"4643_CR79","doi-asserted-by":"publisher","first-page":"104864","DOI":"10.1016\/j.jddst.2023.104864","volume":"88","author":"Z Larian","year":"2023","unstructured":"Larian Z, et al. The folate-chitosan-decorated harmaline nanostructured lipid carrier (FCH-NLC), the efficient selective anticancer nano drug delivery system. J Drug Deliv Sci Technol. 2023;88:104864.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"4643_CR80","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-15-1518","volume":"76","author":"CW Espelin","year":"2016","unstructured":"Espelin CW, et al. Dual HER2 targeting with trastuzumab and liposomal-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer. Cancer Res. 2016;76(6):1517\u201327.","journal-title":"Cancer Res"},{"issue":"10","key":"4643_CR81","first-page":"2195","volume":"14","author":"MP Nikolova","year":"2022","unstructured":"Nikolova MP, Kumar EM, Chavali MSJP. Updates responsive drug delivery based liposome. Veh cancer Treat. 2022;14(10):2195.","journal-title":"Updates responsive drug delivery based liposome Veh cancer Treat"},{"issue":"11","key":"4643_CR82","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, et al. Lipid nanoparticlesfrom liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982\u20137015.","journal-title":"ACS Nano"},{"key":"4643_CR83","doi-asserted-by":"publisher","first-page":"123421","DOI":"10.1016\/j.ijpharm.2023.123421","volume":"646","author":"A Mellinger","year":"2023","unstructured":"Mellinger A, et al. The use of liposomes functionalized with the NFL-TBS.40\u201363 peptide as a targeting agent to cross the in vitro blood-brain barrier and target glioblastoma cells. Int J Pharm. 2023;646:123421.","journal-title":"Int J Pharm"},{"issue":"10","key":"4643_CR84","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/pharmaceutics12100929","volume":"12","author":"D Hattab","year":"2020","unstructured":"Hattab D, Bakhtiar A. Bioengineered siRNA-based nanoplatforms targeting molecular signaling pathways for the treatment of triple negative breast cancer: preclinical and clinical advancements. Pharmaceutics. 2020;12(10):929.","journal-title":"Pharmaceutics"},{"key":"4643_CR85","first-page":"193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao Y, et al. Nanoparticle-based drug delivery cancer therapy its role overcoming drug. Resist. 2020;7:193.","journal-title":"Nanoparticle-based drug delivery cancer therapy its role overcoming drug Resist"},{"issue":"7","key":"4643_CR86","doi-asserted-by":"publisher","first-page":"e0154009","DOI":"10.1371\/journal.pone.0154009","volume":"11","author":"M Ignatiadis","year":"2016","unstructured":"Ignatiadis M, et al. Feasibility study of EndoTAG-1, a tumor endothelial targeting agent, in combination with paclitaxel followed by FEC as induction therapy in HER2-negative breast cancer. PLoS ONE. 2016;11(7):e0154009.","journal-title":"PLoS ONE"},{"issue":"3","key":"4643_CR87","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/ijms24032643","volume":"24","author":"S Wang","year":"2023","unstructured":"Wang S, Chen Y, Guo J, Huang Q. Liposomes for tumor targeted therapy: a review. Int J Mol Sci. 2023;24(3):2643.","journal-title":"Int J Mol Sci"},{"key":"4643_CR88","doi-asserted-by":"publisher","first-page":"109006","DOI":"10.1016\/j.biopha.2019.109006","volume":"116","author":"G Zheng","year":"2019","unstructured":"Zheng G, Zheng M, Yang B, Fu H, Li Y. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Biomed Pharmacother. 2019;116:109006.","journal-title":"Biomed Pharmacother"},{"key":"4643_CR89","doi-asserted-by":"publisher","first-page":"103138","DOI":"10.1016\/j.surfin.2023.103138","volume":"40","author":"P Kumari","year":"2023","unstructured":"Kumari P, Dang S. Dual drug loaded nanostructured lipid carrier for cytotoxic effect against breast cancer-a drug repurposing approach. Surf Interfaces. 2023;40:103138.","journal-title":"Surf interfaces"},{"issue":"11","key":"4643_CR90","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s00432-016-2179-3","volume":"142","author":"H Samadian","year":"2016","unstructured":"Samadian H, et al. Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. J Cancer Res Clin Oncol. 2016;142(11):2217\u201329.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4643_CR91","doi-asserted-by":"crossref","unstructured":"Amreddy N, et al. Chapter Five - Recent advances in nanoparticle-based cancer drug and gene delivery. Advances in Cancer Research. Academic; 2018. pp. 115\u201370. K.D. Tew and P.B. Fisher, Editors.","DOI":"10.1016\/bs.acr.2017.11.003"},{"key":"4643_CR92","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","volume":"60","author":"F Masood","year":"2016","unstructured":"Masood F. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C. 2016;60:569\u201378.","journal-title":"Mater Sci Engineering: C"},{"key":"4643_CR93","doi-asserted-by":"crossref","unstructured":"Idrees H et al. A review of biodegradable natural polymer-based nanoparticles for drug delivery applications. Nanomaterials. 2020. 10(10): p. 1970.","DOI":"10.3390\/nano10101970"},{"issue":"19","key":"4643_CR94","doi-asserted-by":"publisher","first-page":"9336","DOI":"10.3390\/app11199336","volume":"11","author":"V Ravichandran","year":"2021","unstructured":"Ravichandran V, et al. Polysorbate-based drug formulations for brain-targeted drug delivery and anticancer therapy. Appl Sci. 2021;11(19):9336.","journal-title":"Appl Sci"},{"key":"4643_CR95","unstructured":"Vizzotto B. Protective effect of indomethacin-loaded polymeric nanoparticles against oxidative stress-induced cytotoxicity in human breast adenocarcinoma cell model. Revista Brasileira de Cancerologia; 2025."},{"issue":"9","key":"4643_CR96","first-page":"7123","volume":"6","author":"F Mohajer","year":"2023","unstructured":"Mohajer F, Mirhosseini-Eshkevari B, Ahmadi S, Ghasemzadeh MA, Mohammadi Ziarani G, Badiei A, Iravani S. Advanced nanosystems for cancer therapeutics: a review. ACS Appl Nano Mater, 2023;6(9), 7123-7149.","journal-title":"Adv nanosystems cancer therapeutics: Rev"},{"key":"4643_CR97","doi-asserted-by":"crossref","unstructured":"Bodkhe M et al. Micelles: Synthesis, characterization methods, and applications, in Discovery, Disruption, and Future Implications of Nanomaterials. 2024, IGI Global. pp. 101\u2013144.","DOI":"10.4018\/979-8-3693-4397-5.ch004"},{"issue":"5","key":"4643_CR98","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41551-018-0234-x","volume":"2","author":"Y Lu","year":"2018","unstructured":"Lu Y, et al. Micelles with ultralow critical micelle concentration as carriers for drug delivery. Nat Biomedical Eng. 2018;2(5):318\u201325.","journal-title":"Nat biomedical Eng"},{"issue":"1","key":"4643_CR99","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11095-015-1784-1","volume":"33","author":"A Gothwal","year":"2016","unstructured":"Gothwal A, Khan I, Gupta U. Polymeric micelles: recent advancements in the delivery of anticancer drugs. Pharm Res. 2016;33(1):18\u201339.","journal-title":"Pharm Res"},{"issue":"18","key":"4643_CR100","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.7150\/ijms.49801","volume":"17","author":"C Jin","year":"2020","unstructured":"Jin C, et al. Application of nanotechnology in cancer diagnosis and therapy-a mini-review. Int J Med Sci. 2020;17(18):2964.","journal-title":"Int J Med Sci"},{"issue":"15","key":"4643_CR101","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2174\/1568026621666210701144124","volume":"21","author":"A Nasir","year":"2021","unstructured":"Nasir A, et al. Nanotechnology, a tool for diagnostics and treatment of cancer. Curr Top Med Chem. 2021;21(15):1360\u201376.","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"4643_CR102","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.1021\/acs.chemrev.7b00097","volume":"117","author":"SE Sherman","year":"2017","unstructured":"Sherman SE, Xiao Q, Percec V. Mimicking complex biological membranes and their programmable glycan ligands with dendrimersomes and glycodendrimersomes. Chem Rev. 2017;117(9):6538\u2013631.","journal-title":"Chem Rev"},{"issue":"6","key":"4643_CR103","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.3390\/ijms24065430","volume":"24","author":"A Cruz","year":"2023","unstructured":"Cruz A, et al. A Glimpse into dendrimers integration in cancer imaging and theranostics. Int J Mol Sci. 2023;24(6):5430.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4643_CR104","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1140\/epje\/i2016-16059-8","volume":"39","author":"J Petit","year":"2016","unstructured":"Petit J, et al. Vesicles-on-a-chip: A universal microfluidic platform for the assembly of liposomes and polymersomes. Eur Phys J E. 2016;39(6):59.","journal-title":"Eur Phys J E"},{"issue":"2","key":"4643_CR105","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/polym15020318","volume":"15","author":"A Al-Jipouri","year":"2023","unstructured":"Al-Jipouri A, et al. Liposomes or extracellular vesicles: a comprehensive comparison of both lipid bilayer vesicles for pulmonary drug delivery. Polymers. 2023;15(2):318.","journal-title":"Polymers"},{"issue":"1","key":"4643_CR106","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/ijms26010189","volume":"26","author":"P Lorite","year":"2024","unstructured":"Lorite P, Dominguez JN, Palomeque T, Torres MI. Extracellular vesicles: advanced tools for disease diagnosis, monitoring, and therapies. Int J Mol Sci. 2024;26(1):189.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4643_CR107","first-page":"667","volume":"33","author":"DK Jeppesen","year":"2023","unstructured":"Jeppesen DK, et al. Extracell vesicles nanoparticles: Emerg Compl. 2023;33(8):667\u201381.","journal-title":"Extracell vesicles nanoparticles: Emerg complexities"},{"key":"4643_CR108","doi-asserted-by":"publisher","first-page":"590470","DOI":"10.3389\/fphar.2020.590470","volume":"11","author":"W Wei","year":"2021","unstructured":"Wei W, et al. Mesenchymal stem cell\u2013derived exosomes: a promising biological tool in nanomedicine. Front Pharmacol. 2021;11:590470.","journal-title":"Front Pharmacol"},{"issue":"6","key":"4643_CR109","first-page":"1701","volume":"15","author":"J Elzanowska","year":"2021","unstructured":"Elzanowska J, Semira C, Costa-Silva BJMO. DNA extracell vesicles: Biol Clin Aspects. 2021;15(6):1701\u201314.","journal-title":"DNA Extracell vesicles: Biol Clin aspects"},{"issue":"6","key":"4643_CR110","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836\u201348.","journal-title":"Cancer Cell"},{"issue":"7578","key":"4643_CR111","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329\u201335.","journal-title":"Nature"},{"issue":"2","key":"4643_CR112","first-page":"123","volume":"5","author":"M Jaiswal","year":"2015","unstructured":"Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech, 2015;5(2):123-127.","journal-title":"Nanoemulsion: Adv mode drug delivery Syst 3 Biotech"},{"issue":"6","key":"4643_CR113","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/02652048.2020.1767224","volume":"37","author":"M Du","year":"2020","unstructured":"Du M, et al. Design and development of spirulina polysaccharide-loaded nanoemulsions with improved the antitumor effects of paclitaxel. J Microencapsul. 2020;37(6):403\u201312.","journal-title":"J Microencapsul"},{"issue":"5","key":"4643_CR114","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/cancers12051198","volume":"12","author":"C Dianzani","year":"2020","unstructured":"Dianzani C, et al. Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment. Cancers. 2020;12(5):1198.","journal-title":"Cancers"},{"key":"4643_CR115","doi-asserted-by":"publisher","first-page":"119181","DOI":"10.1016\/j.ijpharm.2020.119181","volume":"579","author":"P Mura","year":"2020","unstructured":"Mura P. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: a review. Int J Pharm. 2020;579:119181.","journal-title":"Int J Pharm"},{"issue":"4","key":"4643_CR116","first-page":"579","volume":"8","author":"S Swaminathan","year":"2016","unstructured":"Swaminathan S, Cavalli R, Trotta F. Cyclodextrin\u2010based nanosponges: a versatile platform for cancer nanotherapeutics development. Wiley Interdiscipl Rev Nanomed Nanobiotechnol. 2016;8(4):579\u2013601.","journal-title":"Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol"},{"issue":"1","key":"4643_CR117","first-page":"173","volume":"16","author":"S Gavas","year":"2021","unstructured":"Gavas S, Quazi S. Nanopart cancer therapy. Curr Progress Challenges. 2021;16(1):173.","journal-title":"Nanopart cancer therapy: Curr progress challenges"},{"issue":"1","key":"4643_CR118","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, Akhavan-Sigari R. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1):169.","journal-title":"Mol Cancer"},{"issue":"24","key":"4643_CR119","doi-asserted-by":"publisher","first-page":"17575","DOI":"10.3390\/ijms242417575","volume":"24","author":"G Zahmanova","year":"2023","unstructured":"Zahmanova G, Aljabali AA, Takova K, Minkov G, Tambuwala MM, Minkov I, Lomonossoff GP. Green biologics: harnessing the power of plants to produce pharmaceuticals. Int J Mol Sci. 2023;24(24):17575.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4643_CR120","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.clim.2014.08.003","volume":"154","author":"N Landry","year":"2014","unstructured":"Landry N, Pillet S, Favre D, Poulin JF, Tr\u00e9panier S, Yassine-Diab B, Ward BJ. Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens. Clin Immunol. 2014;154(2):164\u201377.","journal-title":"Clin Immunol"},{"issue":"10261","key":"4643_CR121","first-page":"1491","volume":"396","author":"BJ Ward","year":"2020","unstructured":"Ward BJ, et al. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18\u201364 years) and older adults (\u2265\u200965 years): two multicentre, randomised phase. 3 Trials. 2020;396(10261):1491\u2013503.","journal-title":"3 Trials"},{"issue":"20","key":"4643_CR122","doi-asserted-by":"publisher","first-page":"e1800525","DOI":"10.1002\/adhm.201800525","volume":"7","author":"J Saleem","year":"2018","unstructured":"Saleem J, Wang L, Chen C. Carbon-based nanomaterials for cancer therapy via targeting tumor microenvironment. Adv Healthc Mater. 2018;7(20):e1800525.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"4643_CR123","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/jcp.26899","volume":"234","author":"M Mohajeri","year":"2019","unstructured":"Mohajeri M, Behnam B, Sahebkar A. Biomedical applications of carbon nanomaterials: drug and gene delivery potentials. J Cell Physiol. 2019;234(1):298\u2013319.","journal-title":"J Cell Physiol"},{"issue":"6","key":"4643_CR124","doi-asserted-by":"publisher","first-page":"14726","DOI":"10.33263\/BRIAC116.1472614735","volume":"11","author":"HN Abdelhamid","year":"2021","unstructured":"Abdelhamid HN, Hussein KH. Graphene oxide as a carrier for drug delivery of methotrexate. Biointerface Res Appl Chem. 2021;11(6):14726\u201335.","journal-title":"Biointerface Res Appl Chem"},{"key":"4643_CR125","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jconrel.2018.07.034","volume":"286","author":"J Liu","year":"2018","unstructured":"Liu J, et al. Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy. J Controlled Release. 2018;286:64\u201373.","journal-title":"J Controlled Release"},{"issue":"11","key":"4643_CR126","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1039\/C7NR08747K","volume":"10","author":"Y Tao","year":"2018","unstructured":"Tao Y, et al. Nano-graphene oxide-manganese dioxide nanocomposites for overcoming tumor hypoxia and enhancing cancer radioisotope therapy. Nanoscale. 2018;10(11):5114\u201323.","journal-title":"Nanoscale"},{"issue":"11","key":"4643_CR127","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1007\/s12010-021-03623-8","volume":"193","author":"M Ebrahimi","year":"2021","unstructured":"Ebrahimi M, Teimouri M, Pooladi M. The synergistic anticancer traits of graphene oxide plus doxorubicin against BT474 and MCF7 breast cancer stem cells in vitro. Appl Biochem Biotechnol. 2021;193(11):3586\u2013601.","journal-title":"Appl Biochem Biotechnol"},{"key":"4643_CR128","doi-asserted-by":"crossref","unstructured":"Amina SJ. and B.J.I.j.o.n. Guo. Rev synthesis functionalization gold Nanopart as drug delivery. Veh 2020: 9823\u201357.","DOI":"10.2147\/IJN.S279094"},{"issue":"14","key":"4643_CR129","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2174\/1389450119666180326122831","volume":"19","author":"R Awasthi","year":"2018","unstructured":"Awasthi R, et al. Nanoparticles in cancer treatment: opportunities and obstacles. Curr Drug Targets. 2018;19(14):1696\u2013709.","journal-title":"Curr Drug Targets"},{"issue":"2","key":"4643_CR130","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/thno.67375","volume":"12","author":"Y Huang","year":"2022","unstructured":"Huang Y, et al. Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle. Theranostics. 2022;12(2):796\u2013816.","journal-title":"Theranostics"},{"key":"4643_CR131","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jcis.2020.04.026","volume":"573","author":"L Wan","year":"2020","unstructured":"Wan L, Chen Z, Deng Y, Liao T, Kuang Y, Liu J, Li C. A novel intratumoral pH\/redox-dual-responsive nanoplatform for cancer MR imaging and therapy. J Colloid Interface Sci. 2020;573:263\u201377.","journal-title":"J Colloid Interface Sci"},{"issue":"23","key":"4643_CR132","doi-asserted-by":"publisher","first-page":"1606134","DOI":"10.1002\/adma.201606134","volume":"29","author":"MX Wu","year":"2017","unstructured":"Wu MX, Yang YW. Metal\u2013organic framework (MOF)-based drug\/cargo delivery and cancer therapy. Adv Mater. 2017;29(23):1606134.","journal-title":"Adv Mater"},{"issue":"8","key":"4643_CR133","doi-asserted-by":"publisher","first-page":"2005064","DOI":"10.1002\/smll.202005064","volume":"17","author":"T Wen","year":"2021","unstructured":"Wen T, et al. Versatile nanoscale metal\u2013organic frameworks (nMOFs): an emerging 3D nanoplatform for drug delivery and therapeutic applications. Small. 2021;17(8):2005064.","journal-title":"Small"},{"issue":"37","key":"4643_CR134","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1002\/smll.201500802","volume":"11","author":"W Cai","year":"2015","unstructured":"Cai W, et al. Metal\u2013organic framework-based nanomedicine platforms for drug delivery and molecular imaging. Small. 2015;11(37):4806\u201322.","journal-title":"Small"},{"issue":"8","key":"4643_CR135","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1039\/C6SC01359G","volume":"7","author":"H-X Zhao","year":"2016","unstructured":"Zhao H-X, et al. Theranostic metal\u2013organic framework core\u2013shell composites for magnetic resonance imaging and drug delivery. Chem Sci. 2016;7(8):5294\u2013301.","journal-title":"Chem Sci"},{"issue":"2","key":"4643_CR136","first-page":"627","volume":"12","author":"MJ Ansari","year":"2022","unstructured":"Ansari MJ, et al. Synthesis. Stab Magn Nanopart. 2022;12(2):627\u201338.","journal-title":"Synthesis Stab Magn Nanopart"},{"issue":"5","key":"4643_CR137","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41417-018-0017-2","volume":"25","author":"H Basoglu","year":"2018","unstructured":"Basoglu H, Goncu B, Akbas F. Magnetic nanoparticle-mediated gene therapy to induce Fas apoptosis pathway in breast cancer. Cancer Gene Ther. 2018;25(5):141\u20137.","journal-title":"Cancer Gene Ther"},{"key":"4643_CR138","unstructured":"Hoopes PJ et al. Hypo-fractionated radiation, magnetic nanoparticle hyperthermia and a viral immunotherapy treatment of spontaneous canine cancer. SPIE."},{"issue":"6","key":"4643_CR139","first-page":"e1571","volume":"11","author":"JF Liu","year":"2019","unstructured":"Liu JF, et al. Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting. Wiley Interdiscipl Rev Nanomed Nanobiotechnol. 2019;11(6):e1571.","journal-title":"Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol"},{"issue":"13","key":"4643_CR140","doi-asserted-by":"publisher","first-page":"e1901989","DOI":"10.1002\/adma.201901989","volume":"32","author":"O Adir","year":"2020","unstructured":"Adir O, et al. Integrating artificial intelligence and nanotechnology for precision cancer medicine. Adv Mater. 2020;32(13):e1901989.","journal-title":"Adv Mater"},{"issue":"5","key":"4643_CR141","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3892\/br.2021.1418","volume":"14","author":"S Sim","year":"2021","unstructured":"Sim S, Wong NK. Nanotechnology and its use in imaging and drug delivery. Biomedical Rep. 2021;14(5):42.","journal-title":"Biomedical Rep"},{"issue":"1","key":"4643_CR142","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/molecules23010009","volume":"23","author":"F D\u2019Agata","year":"2017","unstructured":"D\u2019Agata F, et al. Magnetic nanoparticles in the central nervous system: targeting principles, applications and safety issues. Molecules. 2017;23(1):9.","journal-title":"Molecules"},{"issue":"6","key":"4643_CR143","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/jbm.a.36364","volume":"106","author":"H Nosrati","year":"2018","unstructured":"Nosrati H, et al. Enzymatic stimuli-responsive methotrexate\u2010conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition. J Biomedical Mater Res Part A. 2018;106(6):1646\u201354.","journal-title":"J Biomedical Mater Res Part A"},{"key":"4643_CR144","doi-asserted-by":"crossref","unstructured":"Azizi S, Nosrati H, Danafar H. (2020). Simple surface functionalization of magnetic nanoparticles with methotrexate\u2010conjugated bovine serum albumin as a biocompatible drug delivery vehicle. Appl Organomet Chem, 34(4):e5479.","DOI":"10.1002\/aoc.5479"},{"key":"4643_CR145","doi-asserted-by":"publisher","first-page":"103854","DOI":"10.1016\/j.jddst.2022.103854","volume":"77","author":"N Baqeri","year":"2022","unstructured":"Baqeri N, Shahsavari S, Dahouee IA, Shirmard LR. Design of slow-release methotrexate drug delivery system using PHBV magnetic nanoparticles and evaluation of its cytotoxicity. J Drug Deliv Sci Technol. 2022;77:103854.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4643_CR146","doi-asserted-by":"publisher","first-page":"101584","DOI":"10.1016\/j.jddst.2020.101584","volume":"57","author":"D Ahmadi","year":"2020","unstructured":"Ahmadi D, Zarei M, Rahimi M, Khazaie M, Asemi Z, Mir SM, Yousefi B. Preparation and in-vitro evaluation of pH-responsive cationic cyclodextrin coated magnetic nanoparticles for delivery of methotrexate to the Saos-2 bone cancer cells. J Drug Deliv Sci Technol. 2020;57:101584.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"4643_CR147","doi-asserted-by":"publisher","first-page":"104307","DOI":"10.1016\/j.arabjc.2022.104307","volume":"15","author":"J Dou","year":"2022","unstructured":"Dou J, Mi Y, Daneshmand S, Majd MH. The effect of magnetic nanoparticles containing hyaluronic acid and methotrexate on the expression of genes involved in apoptosis and metastasis in A549 lung cancer cell lines. Arab J Chem. 2022;15(12):104307.","journal-title":"Arab J Chem"},{"issue":"1","key":"4643_CR148","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/molecules27010261","volume":"27","author":"MS Lodhi","year":"2022","unstructured":"Lodhi MS, Khalid F, Khan MT, Samra ZQ, Muhammad S, Zhang YJ, Mou K. A novel method of magnetic nanoparticles functionalized with anti-folate receptor antibody and methotrexate for antibody mediated targeted drug delivery. Molecules. 2022;27(1):261.","journal-title":"Molecules"},{"key":"4643_CR149","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejpb.2022.11.024","volume":"182","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang X, Chen X, Cui L, Li Z, Bai Z, Tian F. Construction of pH-responsive polydopamine coated magnetic layered hydroxide nanostructure for intracellular drug delivery. Eur J Pharm Biopharm. 2023;182:12\u201320.","journal-title":"Eur J Pharm Biopharm"},{"key":"4643_CR150","doi-asserted-by":"publisher","first-page":"132869","DOI":"10.1016\/j.snb.2022.132869","volume":"375","author":"Z Li","year":"2023","unstructured":"Li Z, Wan W, Bai Z, Peng B, Wang X, Cui L, Tian F. Construction of pH-responsive nanoplatform from stable magnetic nanoparticles for targeted drug delivery and intracellular imaging. Sens Actuators B. 2023;375:132869.","journal-title":"Sens Actuators B"},{"issue":"5","key":"4643_CR151","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s42250-022-00425-1","volume":"5","author":"H Felenji","year":"2022","unstructured":"Felenji H, Johari B, Moradi M, Gharbavi M, Danafar H. Folic acid-conjugated iron oxide magnetic nanoparticles based on bovine serum albumin (BSA) for targeted delivery of curcumin to suppress liver cancer cells. Chem Afr. 2022;5(5):1627\u201339.","journal-title":"Chem Afr"},{"key":"4643_CR152","doi-asserted-by":"publisher","first-page":"127336","DOI":"10.1016\/j.matchemphys.2023.127336","volume":"297","author":"ES Zadeh","year":"2023","unstructured":"Zadeh ES, Ghanbari N, Salehi Z, Derakhti S, Amoabediny G, Akbari M, Tokmedash MA. Smart pH-responsive magnetic graphene quantum dots nanocarriers for anticancer drug delivery of curcumin. Mater Chem Phys. 2023;297:127336.","journal-title":"Mater Chem Phys"},{"key":"4643_CR153","doi-asserted-by":"publisher","first-page":"113129","DOI":"10.1016\/j.colsurfb.2023.113129","volume":"222","author":"MJC Espinoza","year":"2023","unstructured":"Espinoza MJC, Lin KS, Weng MT, Kunene SC, Lin YS, Liu SY. Magnetic boron nitride nanosheets-based on pH-responsive smart nanocarriers for the delivery of doxorubicin for liver cancer treatment. Colloids Surf B. 2023;222:113129.","journal-title":"Colloids Surf B"},{"key":"4643_CR154","doi-asserted-by":"crossref","unstructured":"Song X, Fu W, Cheang UKJI. Immunomodulation and delivery of macrophages using nano-smooth drug-loaded magnetic microrobots for dual targeting cancer therapy. Iscience 2022. 25(7).","DOI":"10.1016\/j.isci.2022.104507"},{"key":"4643_CR155","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.medntd.2022.100127","volume":"15","author":"J Wang","year":"2022","unstructured":"Wang J, Zhu F, Li K, Xu J, Li P, Fan Y. pH-responsive mesoporous Fe2O3\u2013Au nanomedicine delivery system with magnetic targeting for cancer therapy. Med Novel Technol Devices. 2022;15:100127.","journal-title":"Med Novel Technol Devices"},{"key":"4643_CR156","first-page":"213137","volume":"142","author":"N Sumitha","year":"2022","unstructured":"Sumitha N, Krishna NG, Sailaja GJBA. Multifunctional chitosan ferrogels Target cancer therapy on-demand magnetically triggered drug delivery. Hyperth. 2022;142:213137.","journal-title":"Multifunctional chitosan ferrogels Target cancer therapy on-demand magnetically triggered drug delivery Hyperth"},{"key":"4643_CR157","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.ijbiomac.2022.11.179","volume":"225","author":"Q Liu","year":"2023","unstructured":"Liu Q, Tan Z, Zheng D, Qiu X. pH-responsive magnetic Fe3O4\/carboxymethyl chitosan\/aminated lignosulfonate nanoparticles with uniform size for targeted drug loading. Int J Biol Macromol. 2023;225:1182\u201392.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"4643_CR158","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/magnetochemistry9040106","volume":"9","author":"E Kovrigina","year":"2023","unstructured":"Kovrigina E, Poletaeva Y, Zheng Y, Chubarov A, Dmitrienko E. Nylon-6-coated doxorubicin-loaded magnetic nanoparticles and nanocapsules for cancer treatment. Magnetochemistry. 2023;9(4):106.","journal-title":"Magnetochemistry"},{"key":"4643_CR159","doi-asserted-by":"publisher","first-page":"111611","DOI":"10.1016\/j.matdes.2023.111611","volume":"226","author":"Z Peng","year":"2023","unstructured":"Peng Z, Ning K, Tang X, He R, Zhang DY, Ma Y, Zhai J. A multifunctional DNA repair enzyme and magnetic dual-triggered theranostic nanosystem for intelligent drug delivery. Mater Design. 2023;226:111611.","journal-title":"Mater Design"},{"key":"4643_CR160","doi-asserted-by":"publisher","first-page":"129359","DOI":"10.1016\/j.colsurfa.2022.129359","volume":"648","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Xie P, Li X, Wang Y, Zhang Y, Wang S. Magnetic mesoporous silica nanoparticles mediated redox and pH dual-responsive target drug delivery for combined magnetothermal therapy and chemotherapy. Colloids Surf A. 2022;648:129359.","journal-title":"Colloids Surf A"},{"key":"4643_CR161","doi-asserted-by":"publisher","first-page":"103026","DOI":"10.1016\/j.jddst.2021.103026","volume":"68","author":"P Gonbadi","year":"2022","unstructured":"Gonbadi P, Jalal R, Akhlaghinia B, Ghasemzadeh MS. Tannic acid-modified magnetic hydrotalcite-based MgAl nanoparticles for the in vitro targeted delivery of doxorubicin to the estrogen receptor-overexpressing colorectal cancer cells. J Drug Deliv Sci Technol. 2022;68:103026.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4643_CR162","doi-asserted-by":"publisher","first-page":"105681","DOI":"10.1016\/j.ejps.2020.105681","volume":"158","author":"MJ Martin","year":"2021","unstructured":"Martin MJ, Azcona P, Lassalle V, Gentili C. Doxorubicin delivery by magnetic nanotheranostics enhances the cell death in chemoresistant colorectal cancer-derived cells. Eur J Pharm Sci. 2021;158:105681.","journal-title":"Eur J Pharm Sci"},{"issue":"23","key":"4643_CR163","doi-asserted-by":"publisher","first-page":"13169","DOI":"10.3390\/ijms222313169","volume":"22","author":"HM Yoon","year":"2021","unstructured":"Yoon HM, Kang MS, Choi GE, Kim YJ, Bae CH, Yu YB, Jeong YI. Stimuli-responsive drug delivery of doxorubicin using magnetic nanoparticle conjugated poly (ethylene glycol)-g-chitosan copolymer. Int J Mol Sci. 2021;22(23):13169.","journal-title":"Int J Mol Sci"},{"key":"4643_CR164","doi-asserted-by":"publisher","first-page":"213147","DOI":"10.1016\/j.bioadv.2022.213147","volume":"142","author":"NG Shetake","year":"2022","unstructured":"Shetake NG, Ali M, Kumar A, Bellare J, Pandey BN. Theranostic magnetic nanoparticles enhance DNA damage and mitigate doxorubicin-induced cardio-toxicity for effective multi-modal tumor therapy. Biomater Adv. 2022;142:213147.","journal-title":"Biomaterials Adv"},{"issue":"2","key":"4643_CR165","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/acsami.8b18717","volume":"11","author":"G Di Mandriota","year":"2018","unstructured":"Mandriota G, Di Corato R, Benedetti M, De Castro F, Fanizzi FP, Rinaldi R. Design and application of cisplatin-loaded magnetic nanoparticle clusters for smart chemotherapy. ACS Appl Mater Interfaces. 2018;11(2):1864\u201375.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"4643_CR166","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/pharmaceutics11080395","volume":"11","author":"Y Jabalera","year":"2019","unstructured":"Jabalera Y, Garcia-Pinel B, Ortiz R, Iglesias G, Cabeza L, Prados J, Melguizo C. Oxaliplatin\u2013biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: an in vitro study. Pharmaceutics. 2019;11(8):395.","journal-title":"Pharmaceutics"},{"issue":"3","key":"4643_CR167","doi-asserted-by":"publisher","first-page":"2300812","DOI":"10.1002\/smtd.202300812","volume":"8","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yu Y, Yang Y, Wang Y, Yu C. Engineered silica nanoparticles for nucleic acid delivery. Small Methods. 2024;8(3):2300812.","journal-title":"Small Methods"},{"key":"4643_CR168","unstructured":"Barak M. Synthesis and characterization of highly stable functional silica nanoparticles for LbL assembly. 2018."},{"key":"4643_CR169","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msec.2017.04.049","volume":"78","author":"Y He","year":"2017","unstructured":"He Y, Liang S, Long M, Xu H. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. Mater Sci Eng C. 2017;78:12\u20137.","journal-title":"Mater Sci Engineering: C"},{"issue":"1","key":"4643_CR170","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1038\/s41598-020-71071-1","volume":"10","author":"M Chen","year":"2020","unstructured":"Chen M, Hu J, Wang L, Li Y, Zhu C, Chen C, Zhang Z. Targeted and redox-responsive drug delivery systems based on carbonic anhydrase IX-decorated mesoporous silica nanoparticles for cancer therapy. Sci Rep. 2020;10(1):14447.","journal-title":"Sci Rep"},{"key":"4643_CR171","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jconrel.2022.07.029","volume":"349","author":"A Almeida","year":"2022","unstructured":"Almeida A, et al. Oral delivery of camptothecin-loaded multifunctional chitosan-based micelles is effective in reduce colorectal cancer. J Controlled Release. 2022;349:731\u201343.","journal-title":"J Controlled Release"},{"issue":"1","key":"4643_CR172","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1556\/1646.11.2019.04","volume":"11","author":"A Maurya","year":"2019","unstructured":"Maurya A, et al. Strategic use of nanotechnology in drug targeting and its consequences on human health: a focused review. Interventional Med Appl Sci. 2019;11(1):38\u201354.","journal-title":"Interventional Med Appl Sci"},{"issue":"3","key":"4643_CR173","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/molecules28031498","volume":"28","author":"GYW Tseu","year":"2023","unstructured":"Tseu GYW, Kamaruzaman KA. A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast cancer. Molecules. 2023;28(3):1498.","journal-title":"Molecules"},{"issue":"1","key":"4643_CR174","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1021\/acs.chemmater.7b03924","volume":"30","author":"M Li","year":"2018","unstructured":"Li M, Luo Z, Zhao Y. Self-assembled hybrid nanostructures: versatile multifunctional nanoplatforms for cancer diagnosis and therapy. Chem Mater. 2018;30(1):25\u201353.","journal-title":"Chem Mater"},{"issue":"15","key":"4643_CR175","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.3390\/molecules28155694","volume":"28","author":"F Yanar","year":"2023","unstructured":"Yanar F, Carugo D, Zhang X. Hybrid nanoplatforms comprising organic nanocompartments encapsulating inorganic nanoparticles for enhanced drug delivery and bioimaging applications. Molecules. 2023;28(15):5694.","journal-title":"Molecules"},{"issue":"13","key":"4643_CR176","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2174\/0929867327666200525161359","volume":"28","author":"R Petrilli","year":"2021","unstructured":"Petrilli R, et al. Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles. Curr Med Chem. 2021;28(13):2485\u2013520.","journal-title":"Curr Med Chem"},{"issue":"1","key":"4643_CR177","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12935-022-02679-8","volume":"22","author":"HE Marei","year":"2022","unstructured":"Marei HE, Cenciarelli C, Hasan A. Potential of antibody\u2013drug conjugates (ADCs) for cancer therapy. Cancer Cell Int. 2022;22(1):255.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4643_CR178","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-021-01459-y","volume":"23","author":"E Ferraro","year":"2021","unstructured":"Ferraro E, Drago JZ, Modi S. Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions. Breast Cancer Res. 2021;23(1):84.","journal-title":"Breast Cancer Res"},{"issue":"44","key":"4643_CR179","doi-asserted-by":"publisher","first-page":"2009860","DOI":"10.1002\/adfm.202009860","volume":"31","author":"TG Dacoba","year":"2021","unstructured":"Dacoba TG, et al. Nano-oncologicals: a tortoise trail reaching new avenues. Adv Funct Mater. 2021;31(44):2009860.","journal-title":"Adv Funct Mater"},{"issue":"4","key":"4643_CR180","first-page":"e1988","volume":"16","author":"H Guo","year":"2024","unstructured":"Guo H, Mi P. Polymer\u2013drug and polymer\u2013protein conjugated nanocarriers: design, drug delivery, imaging, therapy, and clinical applications. Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol. 2024;16(4):e1988.","journal-title":"Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol"},{"issue":"9","key":"4643_CR181","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","volume":"13","author":"AA D\u2019souza","year":"2016","unstructured":"D\u2019souza AA, Shegokar R. Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications. Expert Opin Drug Deliv. 2016;13(9):1257\u201375.","journal-title":"Expert Opin Drug Deliv"},{"issue":"26","key":"4643_CR182","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.7150\/thno.38587","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu X, Jiang J, Meng H. Transcytosis-An effective targeting strategy that is complementary to EPR effect for pancreatic cancer nano drug delivery. Theranostics. 2019;9(26):8018.","journal-title":"Theranostics"},{"issue":"1","key":"4643_CR183","doi-asserted-by":"publisher","first-page":"20230133","DOI":"10.1515\/ntrev-2023-0133","volume":"12","author":"W Xie","year":"2023","unstructured":"Xie W, Liu Y, Lin J. Advances in organic\u2013inorganic nanocomposites for cancer imaging and therapy. Nanatechnol Rev 2023;12(1):20230133.","journal-title":"Nanatechnol Reviews"},{"issue":"2","key":"4643_CR184","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/polym14020351","volume":"14","author":"M Zhang","year":"2022","unstructured":"Zhang M, et al. Polymer-based nanofiber\u2013nanoparticle hybrids and their medical applications. Polymers. 2022;14(2):351.","journal-title":"Polymers"},{"key":"4643_CR185","doi-asserted-by":"publisher","first-page":"1249134","DOI":"10.3389\/fchem.2023.1249134","volume":"11","author":"S Malehmir","year":"2023","unstructured":"Malehmir S, et al. A review: hemocompatibility of magnetic nanoparticles and their regenerative medicine, cancer therapy, drug delivery, and bioimaging applications. Front Chem. 2023;11:1249134.","journal-title":"Front Chem"},{"key":"4643_CR186","doi-asserted-by":"crossref","unstructured":"Singh V. Theranostics: integrated diagnostics and therapy using nanomedicine. Nanomedicine: Innovations, Applications, and Breakthroughs in the Quest for Health and Medicine\u2019s Future. Springer; 2024. pp. 505\u201330.","DOI":"10.1007\/978-3-031-72467-1_17"},{"key":"4643_CR187","doi-asserted-by":"publisher","first-page":"113991","DOI":"10.1016\/j.jconrel.2025.113991","volume":"385","author":"RM Pallares","year":"2025","unstructured":"Pallares RM, et al. Clinical cancer nanomedicines. J Controlled Release. 2025;385:113991.","journal-title":"J Controlled Release"},{"key":"4643_CR188","doi-asserted-by":"publisher","first-page":"115751","DOI":"10.1016\/j.jpba.2023.115751","volume":"236","author":"S Giordani","year":"2023","unstructured":"Giordani S, Marassi V, Zattoni A, Roda B, Reschiglian P. Liposomes characterization for market approval as pharmaceutical products: analytical methods, guidelines and standardized protocols. J Pharm Biomed Anal. 2023;236:115751.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"4643_CR189","first-page":"155","volume":"15","author":"JE Cortes","year":"2022","unstructured":"Cortes JE, et al. Efficacy and safety of CPX-351 versus 7\u2009+\u20093 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk\/secondary AML: post hoc analysis of a randomized. Phase 3 trial. 2022;15(1):155.","journal-title":"Phase 3 trial"},{"issue":"10","key":"4643_CR190","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/bjc.2017.67","volume":"116","author":"U Von Pelzer","year":"2017","unstructured":"Pelzer U, Blanc JF, Melisi D, Cubillo A, Von Hoff DD, Wang-Gillam A, Hubner RA. Quality-adjusted survival with combination nal-IRI+ 5-FU\/LV vs 5-FU\/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis. Br J Cancer. 2017;116(10):1247\u201353.","journal-title":"Br J Cancer"},{"issue":"3","key":"4643_CR191","first-page":"592","volume":"25","author":"J Baselga","year":"2014","unstructured":"Baselga J, et al. Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic. Breast Cancer. 2014;25(3):592\u20138.","journal-title":"Breast Cancer"},{"issue":"6","key":"4643_CR192","first-page":"571","volume":"41","author":"Y Kim","year":"2018","unstructured":"Kim Y, Park EJ. J.A.o.p.r. Na. Recent progress dendrimer-based. Nanomed Dev. 2018;41(6):571\u201382.","journal-title":"Recent progress dendrimer-based Nanomed Dev"},{"issue":"3","key":"4643_CR193","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4143\/crt.2016.289","volume":"49","author":"IH Park","year":"2017","unstructured":"Park IH, Sohn JH, Kim SB, Lee KS, Chung JS, Lee SH, Ro J. An open-label, randomized, parallel, phase III trial evaluating the efficacy and safety of polymeric micelle-formulated paclitaxel compared to conventional cremophor EL-based paclitaxel for recurrent or metastatic HER2-negative breast cancer. Cancer Res Treat. 2017;49(3):569\u201377.","journal-title":"Cancer Res Treat"},{"issue":"8","key":"4643_CR194","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S1470-2045(19)30326-2","volume":"20","author":"S Bonvalot","year":"2019","unstructured":"Bonvalot S, Rutkowski PL, Thariat J, Carr\u00e8re S, Ducassou A, Sunyach MP, Papai Z. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc): a multicentre, phase 2\u20133, randomised, controlled trial. Lancet Oncol. 2019;20(8):1148\u201359.","journal-title":"Lancet Oncol"},{"issue":"2","key":"4643_CR195","doi-asserted-by":"publisher","first-page":"179","DOI":"10.21037\/tau-21-723","volume":"11","author":"R Malek","year":"2022","unstructured":"Malek R, Wu ST, Serrano D, Tho T, Umbas R, Teoh J, Chiong E. ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD\u00ae) in Asian men with prostate cancer. Transl Androl Urol. 2022;11(2):179.","journal-title":"Translational Androl Urol"},{"issue":"3","key":"4643_CR196","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijrobp.2022.06.089","volume":"114","author":"EJ Van Koay","year":"2022","unstructured":"Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Krishnan S. Nab-paclitaxel, capecitabine, and radiation therapy after induction chemotherapy in treating patients with locally advanced and borderline resectable pancreatic cancer: phase 1 trial and imaging-based biomarker validation. Int J Radiation Oncology* Biology* Phys. 2022;114(3):444\u201353.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"2","key":"4643_CR197","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","volume":"103","author":"K Maier-Hauff","year":"2011","unstructured":"Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Jordan A. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103(2):317\u201324.","journal-title":"J Neurooncol"},{"issue":"8","key":"4643_CR198","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C9RA10857B","volume":"10","author":"KY Hern\u00e1ndez-Giottonini","year":"2020","unstructured":"Hern\u00e1ndez-Giottonini KY, et al. PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters. RSC Adv. 2020;10(8):4218\u201331.","journal-title":"RSC Adv"},{"key":"4643_CR199","doi-asserted-by":"crossref","unstructured":"Franco YL, Vaidya TR, Ait-Oudhia S. Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer. Breast Cancer: Targets Therapy, 2018: pp. 131\u201341.","DOI":"10.2147\/BCTT.S170239"},{"issue":"1","key":"4643_CR200","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","volume":"9","author":"B Wang","year":"2024","unstructured":"Wang B, et al. Current advance of nanotechnology in diagnosis and treatment for malignant tumors. Signal Transduct Target Therapy. 2024;9(1):200.","journal-title":"Signal Transduct Target Therapy"},{"issue":"3","key":"4643_CR201","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.medj.2022.12.001","volume":"4","author":"P Zhang","year":"2023","unstructured":"Zhang P, et al. Cancer nanomedicine toward clinical translation: obstacles, opportunities, and future prospects. Med. 2023;4(3):147\u201367.","journal-title":"Med"},{"issue":"1","key":"4643_CR202","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.apsb.2024.12.007","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Recent advances in the bench-to-bedside translation of cancer nanomedicines. Acta Pharm Sinica B. 2025;15(1):97\u2013122.","journal-title":"Acta Pharm Sinica B"},{"issue":"1","key":"4643_CR203","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12672-025-02469-4","volume":"16","author":"P Samathoti","year":"2025","unstructured":"Samathoti P, et al. The role of nanomedicine and artificial intelligence in cancer health care: individual applications and emerging integrations\u2014a narrative review. Discover Oncol. 2025;16(1):697.","journal-title":"Discover Oncol"},{"issue":"10","key":"4643_CR204","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"D Bobo","year":"2016","unstructured":"Bobo D, et al. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date: bobo. Pharm Res. 2016;33(10):2373\u201387.","journal-title":"Pharm Res"},{"issue":"1","key":"4643_CR205","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1):169.","journal-title":"Mol Cancer"},{"issue":"3","key":"4643_CR206","first-page":"1685","volume":"23","author":"D Mundekkad","year":"2022","unstructured":"Mundekkad D, Cho WC. Nanoparticles in clinical translation for cancer therapy. Int J Mol Sci 2022;23(3):1685.","journal-title":"Nanopart Clin translation cancer therapy"},{"issue":"2","key":"4643_CR207","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12253-019-00643-y","volume":"26","author":"U Kim","year":"2020","unstructured":"Kim U, et al. Phloretin inhibits the human prostate cancer cells through the generation of reactive oxygen species. Pathol Oncol Res. 2020;26(2):977\u201384.","journal-title":"Pathol Oncol Res"},{"key":"4643_CR208","doi-asserted-by":"crossref","unstructured":"Raj S, et al. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. Seminars in cancer biology. Elsevier; 2021.","DOI":"10.1016\/j.semcancer.2019.11.002"},{"issue":"11","key":"4643_CR209","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.18632\/oncotarget.23859","volume":"9","author":"M Buttacavoli","year":"2017","unstructured":"Buttacavoli M, et al. Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation. Oncotarget. 2017;9(11):9685.","journal-title":"Oncotarget"},{"issue":"1","key":"4643_CR210","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41467-018-02915-8","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang H, et al. Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance. Nat Commun. 2018;9(1):562.","journal-title":"Nat Commun"},{"issue":"11","key":"4643_CR211","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/antiox8110505","volume":"8","author":"MJ L\u00f3pez Grueso","year":"2019","unstructured":"L\u00f3pez Grueso MJ, Valero T, Carmona-Hidalgo RM, Lagal Ruiz B, Peinado DJ, McDonagh J, Padilla B, Pe\u00f1a CA. Peroxiredoxin 6 down-regulation induces metabolic remodeling and cell cycle arrest in HepG2 cells. Antioxidants. 2019;8(11):505.","journal-title":"Antioxidants"},{"key":"4643_CR212","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.colsurfb.2017.03.005","volume":"153","author":"S Khan","year":"2017","unstructured":"Khan S, Ansari AA, Khan AA, Abdulla M, Al-Obaid O, Ahmad R. In vitro evaluation of cytotoxicity, possible alteration of apoptotic regulatory proteins, and antibacterial activity of synthesized copper oxide nanoparticles. Colloids Surf B. 2017;153:320\u20136.","journal-title":"Colloids Surf B"},{"issue":"15","key":"4643_CR213","first-page":"7798","volume":"22","author":"EG Varlamova","year":"2021","unstructured":"Varlamova EG, et al. Mechanisms of the cytotoxic effect of selenium nanoparticles. different. Hum Cancer Cell Lines. 2021;22(15):7798.","journal-title":"different Hum cancer cell lines"},{"key":"4643_CR214","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jphotobiol.2016.06.046","volume":"162","author":"X Zhao","year":"2016","unstructured":"Zhao X, Takabayashi F, Ibuki Y. Coexposure to silver nanoparticles and ultraviolet A synergistically enhances the phosphorylation of histone H2AX. J Photochem Photobiol B. 2016;162:213\u201322.","journal-title":"J Photochem Photobiol B"},{"issue":"8","key":"4643_CR215","doi-asserted-by":"publisher","first-page":"267","DOI":"10.15698\/cst2019.08.195","volume":"3","author":"Y Huai","year":"2019","unstructured":"Huai Y, et al. Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine. Cell Stress. 2019;3(8):267.","journal-title":"Cell Stress"},{"issue":"1","key":"4643_CR216","first-page":"11","volume":"7","author":"Y Mi","year":"2016","unstructured":"Mi Y, et al. Application. Nanatechnol Cancer Radiotherapy. 2016;7(1):11.","journal-title":"Application Nanatechnol cancer radiotherapy"},{"key":"4643_CR217","doi-asserted-by":"crossref","unstructured":"Guryev EL, Volodina NO, Shilyagina NY, Gudkov SV, Balalaeva IV, Volovetskiy AB, Deyev SM. (2018). Radioactive (90Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer. Proc Natl Acad Sci, 115(39), 9690-9695.","DOI":"10.1073\/pnas.1809258115"},{"key":"4643_CR218","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.biomaterials.2017.10.048","volume":"154","author":"J Deng","year":"2018","unstructured":"Deng J, Xu S, Hu W, Xun X, Zheng L, Su M. Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer. Biomaterials. 2018;154:24\u201333.","journal-title":"Biomaterials"},{"key":"4643_CR219","first-page":"167","volume":"7","author":"JB Vines","year":"2019","unstructured":"Vines JB, et al. Gold. Nanopart Photothermal Cancer Therapy. 2019;7:167.","journal-title":"Gold Nanopart photothermal cancer therapy"},{"key":"4643_CR220","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.2147\/IJN.S171130","volume":"13","author":"A Rivera-Rodriguez","year":"2018","unstructured":"Rivera-Rodriguez A, Chiu-Lam A, Morozov VM, Ishov AM, Rinaldi C. Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cells. Int J Nanomed. 2018;13:4771\u20139.","journal-title":"Int J Nanomed"},{"issue":"9","key":"4643_CR221","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/jop.12921","volume":"48","author":"CJ Legge","year":"2019","unstructured":"Legge CJ, Colley HE, Lawson MA, Rawlings AE. Targeted magnetic nanoparticle hyperthermia for the treatment of oral cancer. J Oral Pathol Med. 2019;48(9):803\u20139.","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"4643_CR222","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10103-015-1847-x","volume":"31","author":"M Heidari","year":"2016","unstructured":"Heidari M, Sattarahmady N, Azarpira N, Heli H, Mehdizadeh AR, Zare T. Photothermal cancer therapy by gold-ferrite nanocomposite and near-infrared laser in animal model. Lasers Med Sci. 2016;31(2):221\u20137.","journal-title":"Lasers Med Sci"},{"issue":"7","key":"4643_CR223","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1039\/C9BM00333A","volume":"7","author":"YC Ma","year":"2019","unstructured":"Ma YC, Zhu YH, Tang XF, Hang LF, Jiang W, Li M, Wang YC. Au nanoparticles with enzyme-mimicking activity-ornamented ZIF-8 for highly efficient photodynamic therapy. Biomater Sci. 2019;7(7):2740\u20138.","journal-title":"Biomaterials Sci"},{"issue":"1","key":"4643_CR224","first-page":"76","volume":"32","author":"P Kaur","year":"2016","unstructured":"Kaur, P., Aliru, M. L., Chadha, A. S., Asea, A., & Krishnan, S. (2016). Hyperthermia using nanoparticles\u2013promises and pitfalls. Int J Hyperthermia, 32(1), 76-88.","journal-title":"Hyperth using nanoparticles\u2013promises pitfalls"},{"issue":"30","key":"4643_CR225","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1039\/C9TB00215D","volume":"7","author":"N Gonz\u00e1lez-Ballesteros","year":"2019","unstructured":"Gonz\u00e1lez-Ballesteros N, Diego-Gonz\u00e1lez L, Lastra-Valdor M, Rodr\u00edguez-Arg\u00fcelles MC, Grimaldi M, Cavazza A, Sim\u00f3n-V\u00e1zquez R. Immunostimulant and biocompatible gold and silver nanoparticles synthesized using the Ulva intestinalis L. aqueous extract. J Mater Chem B. 2019;7(30):4677\u201391.","journal-title":"J Mater Chem B"},{"issue":"3","key":"4643_CR226","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ymthe.2018.11.012","volume":"27","author":"M Das","year":"2019","unstructured":"Das M, et al. Nanoparticle delivery of RIG-I agonist enables effective and safe adjuvant therapy in pancreatic cancer. Mol Ther. 2019;27(3):507\u201317.","journal-title":"Mol Ther"},{"issue":"sup1","key":"4643_CR227","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/21691401.2018.1430585","volume":"46","author":"S Bagheri","year":"2018","unstructured":"Bagheri S, Yasemi M, Safaie-Qamsari E, Rashidiani J, Abkar M, Hassani M, Kooshki H. Using gold nanoparticles in diagnosis and treatment of melanoma cancer. Artif cells Nanomed Biotechnol. 2018;46(sup1):462\u201371.","journal-title":"Artif cells Nanomed Biotechnol"},{"key":"4643_CR228","doi-asserted-by":"crossref","unstructured":"Afzal M, et al. Nanomedicine in treatment of breast cancer\u2013A challenge to conventional therapy. Seminars in cancer biology. Elsevier; 2021.","DOI":"10.1016\/j.semcancer.2019.12.016"},{"issue":"45","key":"4643_CR229","doi-asserted-by":"publisher","first-page":"30722","DOI":"10.1021\/acsami.6b10029","volume":"8","author":"WY Huang","year":"2016","unstructured":"Huang WY, Lin JN, Hsieh JT, Chou SC, Lai CH, Yun EJ, Lin YH. Nanoparticle targeting CD44-positive cancer cells for site-specific drug delivery in prostate cancer therapy. ACS Appl Mater Interfaces. 2016;8(45):30722\u201334.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"4643_CR230","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s11671-016-1734-9","volume":"11","author":"G Bisht","year":"2016","unstructured":"Bisht G, Rayamajhi S, Kc B, Paudel SN, Karna D, Shrestha BG. Synthesis, characterization, and study of in vitro cytotoxicity of ZnO-Fe3O4 magnetic composite nanoparticles in human breast cancer cell line (MDA-MB-231) and mouse fibroblast (NIH 3T3). Nanoscale Res Lett. 2016;11(1):537.","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"4643_CR231","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/pharmaceutics15010216","volume":"15","author":"AC Marques","year":"2023","unstructured":"Marques AC, Costa PC, Velho S, Amaral MH. Lipid nanoparticles functionalized with antibodies for anticancer drug therapy. Pharmaceutics. 2023;15(1):216.","journal-title":"Pharmaceutics"},{"issue":"4","key":"4643_CR232","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/01635581.2019.1643031","volume":"72","author":"A Kaplan","year":"2020","unstructured":"Kaplan A, Kutlu HM, Ciftci GA. Fe3O4 nanopowders: genomic and apoptotic evaluations on A549 lung adenocarcinoma cell line. Nutr Cancer. 2020;72(4):708\u201321.","journal-title":"Nutr Cancer"},{"issue":"8","key":"4643_CR233","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/jphp.13098","volume":"71","author":"MF Attia","year":"2019","unstructured":"Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol. 2019;71(8):1185\u201398.","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"4643_CR234","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.3390\/cancers14122868","volume":"14","author":"M Sharifi","year":"2022","unstructured":"Sharifi M, Cho WC, Ansariesfahani A, Tarharoudi R, Malekisarvar H, Sari S, Falahati M. An updated review on EPR-based solid tumor targeting nanocarriers for cancer treatment. Cancers. 2022;14(12):2868.","journal-title":"Cancers"},{"issue":"17","key":"4643_CR235","doi-asserted-by":"publisher","first-page":"9118","DOI":"10.3390\/ijms22179118","volume":"22","author":"W Xia","year":"2021","unstructured":"Xia W, Tao Z, Zhu B, Zhang W, Liu C, Chen S, Song M. Targeted delivery of drugs and genes using polymer nanocarriers for cancer therapy. Int J Mol Sci. 2021;22(17):9118.","journal-title":"Int J Mol Sci"},{"issue":"26","key":"4643_CR236","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.7150\/thno.37204","volume":"9","author":"A Dhaliwal","year":"2019","unstructured":"Dhaliwal A, Zheng G. Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery. Theranostics. 2019;9(26):8091.","journal-title":"Theranostics"},{"issue":"1","key":"4643_CR237","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","volume":"16","author":"S Gavas","year":"2021","unstructured":"Gavas S, Quazi S, Karpi\u0144ski TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett. 2021;16(1):173.","journal-title":"Nanoscale Res Lett"},{"issue":"12","key":"4643_CR238","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1158\/1535-7163.MCT-18-0696","volume":"17","author":"W Islam","year":"2018","unstructured":"Islam W, et al. Augmentation of the enhanced permeability and retention effect with nitric oxide\u2013generating agents improves the therapeutic effects of nanomedicines. Mol Cancer Ther. 2018;17(12):2643\u201353.","journal-title":"Mol Cancer Ther"},{"key":"4643_CR239","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.biomaterials.2017.09.021","volume":"148","author":"Q Chen","year":"2017","unstructured":"Chen Q, et al. Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy. Biomaterials. 2017;148:69\u201380.","journal-title":"Biomaterials"},{"issue":"29","key":"4643_CR240","doi-asserted-by":"publisher","first-page":"1902440","DOI":"10.1002\/adfm.201902440","volume":"29","author":"H Wang","year":"2019","unstructured":"Wang H, et al. Hyaluronidase with pH-responsive dextran modification as an adjuvant nanomedicine for enhanced photodynamic\u2010immunotherapy of cancer. Adv Funct Mater. 2019;29(29):1902440.","journal-title":"Adv Funct Mater"},{"issue":"7","key":"4643_CR241","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","volume":"5","author":"JE Murphy","year":"2019","unstructured":"Murphy JE, et al. Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial. JAMA Oncol. 2019;5(7):1020\u20137.","journal-title":"JAMA Oncol"},{"issue":"26","key":"4643_CR242","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.7150\/thno.37204","volume":"9","author":"A Dhaliwal","year":"2019","unstructured":"Dhaliwal A, Zheng G. Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: designing a new perspective in nanomedicine delivery. Theranostics. 2019;9(26):8091\u2013108.","journal-title":"Theranostics"},{"issue":"9","key":"4643_CR243","first-page":"1007","volume":"5","author":"MO Durymanov","year":"2015","unstructured":"Durymanov, M. O., Rosenkranz, A. A., & Sobolev, A. S. (2015). Current approaches for improving intratumoral accumulation and distribution of nanomedicines. Theranostics, 5(9), 1007.","journal-title":"Curr approaches improving intratumoral accumulation distribution nanomedicines"},{"issue":"8","key":"4643_CR244","first-page":"1589","volume":"16","author":"X Gu","year":"2024","unstructured":"Gu X, Minko TJC. Target nanoparticle-based. Diagn Treat Options Pancreat Cancer. 2024;16(8):1589.","journal-title":"Target nanoparticle-based Diagn Treat options Pancreat cancer"},{"key":"4643_CR245","doi-asserted-by":"crossref","unstructured":"Amreddy N et al. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy. Int J Nanomed, 2015: 6773\u201388.","DOI":"10.2147\/IJN.S93237"},{"key":"4643_CR246","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.colsurfb.2017.11.015","volume":"161","author":"J Cao","year":"2018","unstructured":"Cao J, Zhang Y, Wu Y, Wu J, Wang W, Wu Q, Yuan Z. The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles. Colloids Surf B. 2018;161:508\u201318.","journal-title":"Colloids Surf B"},{"issue":"13","key":"4643_CR247","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1039\/D2RA07863E","volume":"13","author":"MJ Nirmala","year":"2023","unstructured":"Nirmala MJ, Kizhuveetil U, Johnson A, Nagarajan R, Muthuvijayan V. Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv. 2023;13(13):8606\u201329.","journal-title":"RSC Adv"},{"issue":"3","key":"4643_CR248","first-page":"213","volume":"22","author":"H Jin","year":"2023","unstructured":"Jin H, Wang L, Bernards R. Rational combinations of targeted cancer therapies: background, advances and challenges. Nat Rev Drug Discov, 2023;22(3):213-234.","journal-title":"Ration combinations Target cancer therapies: Backgr Adv challenges"},{"issue":"3","key":"4643_CR249","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"S \u0110or\u0111evi\u0107","year":"2022","unstructured":"\u0110or\u0111evi\u0107 S, Gonzalez MM, Conejos-S\u00e1nchez I, Carreira B, Pozzi S, Ac\u00farcio RC, Vicent MJ. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res. 2022;12(3):500\u201325.","journal-title":"Drug delivery translational Res"},{"issue":"36","key":"4643_CR250","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.2174\/0929867328666210406115529","volume":"28","author":"I Cs\u00f3ka","year":"2021","unstructured":"Cs\u00f3ka I, Ismail R, J\u00f3j\u00e1rt-Laczkovich O, Pallagi E. Regulatory considerations, challenges and risk-based approach in nanomedicine development. Curr Med Chem. 2021;28(36):7461\u201376.","journal-title":"Curr Med Chem"},{"key":"4643_CR251","first-page":"343","volume-title":"Future Perspectives and Challenges: Clinical Translation and Regulatory Aspects, Scale-Up and Manufacturing, Ethical Considerations","author":"A Das","year":"2019","unstructured":"Das A, Pathak K, Saikia R, Pathak MP, Gogoi U, Das D, Sonowal S. Future perspectives and challenges: clinical translation and regulatory aspects, scale-up and manufacturing, ethical considerations. Nanocarriers Nucleic Acids Proteins; 2019. pp. 343\u201370."},{"issue":"37","key":"4643_CR252","first-page":"e202511230","volume":"64","author":"X Wang","year":"2025","unstructured":"Wang, X., Tang, Y., & Li, Q. (2025). Mitochondria\u2010targeted molecular tools in precise tumor therapy. Angewandte Chemie International Edition, 64(37), e202511230.","journal-title":"Mitochondria-Targeted Mol Tools Precise Tumor Therapy"},{"issue":"10","key":"4643_CR253","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","volume":"4","author":"KA Autio","year":"2018","unstructured":"Autio KA, Dreicer R, Anderson J, Garcia JA, Alva A, Hart LL, Scher HI. Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a phase 2 clinical trial. JAMA Oncol. 2018;4(10):1344\u201351.","journal-title":"JAMA Oncol"},{"issue":"8","key":"4643_CR254","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S1470-2045(18)30332-2","volume":"19","author":"PC Lyon","year":"2018","unstructured":"Lyon PC, Gray MD, Mannaris C, Folkes LK, Stratford M, Campo L, Coussios CC. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial. Lancet Oncol. 2018;19(8):1027\u201339.","journal-title":"Lancet Oncol"},{"issue":"7\u20138","key":"4643_CR255","first-page":"627","volume":"23","author":"J Kim","year":"2015","unstructured":"Kim J, Wilson DR, Zamboni CG, Green J.J. Targeted polymeric nanoparticles for cancer gene therapy. J Drug Target 2015;23(7-8):627-641.","journal-title":"Target Polym Nanopart cancer gene therapy"},{"issue":"1","key":"4643_CR256","first-page":"126","volume":"9","author":"S Gao","year":"2019","unstructured":"Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Wang, Q., ... & Shi, K. (2019). Engineering nanoparticles for targeted remodeling of the tumor microenvironment to improve cancer immunotherapy. Theranostics, 9(1), 126.","journal-title":"Eng Nanopart Target remodeling tumor microenvironment improve cancer immunotherapy"},{"issue":"12","key":"4643_CR257","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/cac2.12366","volume":"42","author":"KS Allemailem","year":"2022","unstructured":"Allemailem KS, Alsahli MA, Almatroudi A, Alrumaihi F, Alkhaleefah FK, Rahmani AH, Khan AA. Current updates of CRISPR\/Cas9\u2010mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management. Cancer Commun. 2022;42(12):1257\u201387.","journal-title":"Cancer Commun"},{"key":"4643_CR258","doi-asserted-by":"crossref","unstructured":"Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. (2023). Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics, 15(7), 1916.","DOI":"10.3390\/pharmaceutics15071916"},{"issue":"1","key":"4643_CR259","first-page":"20","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer, 2017;17(1), 20-37.","journal-title":"Cancer nanomedicine: progress challenges opportunities"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04643-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04643-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04643-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:03:12Z","timestamp":1781092992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04643-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":259,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4643"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04643-1","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The manuscript has been approved for publication by all the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"254"}}